Delivery Order SPE2DB20D1004-SPE2DB24FG4V7
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Lantus (insulin glargine) 100 unit/mL vials. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,187.40 and a period of performance through September 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide this critical diabetes medication to support military treatment facilities and other federal healthcare...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin, a critical medication for the management of diabetes. The contract has a ceiling value of $2,672.10 and a completion date of February 15, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $2,351.59 and a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Lantus 100 unit/mL vial, 10 mL, a prescription insulin medication. The contract has a firm fixed price of $7,641.03 and a completion date of September 10, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside contract. This contract is likely part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The contract is for the delivery of 4,564,571,290 units of Lantus Solostar 100 unit/mL 3mL, a prescription insulin medication. The contract has a ceiling value of $1,420.88 and an ultimate completion date of May 13, 2024. This delivery order is issued against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The contract has a ceiling value of $2,375.20 and a completion date of August 7, 2024. This award is a firm fixed price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin medication. The contract has a ceiling value of $1,291.10 and a performance period through April 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,063.88, is for the delivery of Lantus 100 unit/mL vial, a medication used to treat diabetes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lantus 100 unit/mL vial, 10mL, a medication used to treat diabetes. The contract has a ceiling value of $1,223.39 and runs through December 18, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin products. The contract has a ceiling value of $3,523.08 and an ultimate completion date of August 5, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB24FG4V7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus 100 unit/ml vials, a brand-name insulin product used for the treatment of diabetes. The contract has a ceiling value of $2,753.96 and an ultimate completion date of July 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC allows for the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was competitively awarded.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/18/24 |